For a 39‑week + 6‑day nulliparous woman with a singleton pregnancy and a closed cervix, is it safer to continue expectant management rather than induce labor?

No, Induction at 39-40 Weeks is Actually Safer Than Waiting

For a low-risk nulliparous woman at 39 weeks + 6 days with a closed cervix, proceeding with induction of labor is safer than expectant management, as it reduces cesarean delivery rates and hypertensive complications without increasing neonatal risks.

Key Evidence from the ARRIVE Trial

The landmark ARRIVE trial fundamentally changed our understanding of elective induction at 39 weeks 1, 2. This large multicenter randomized controlled trial of over 6,000 low-risk nulliparous women demonstrated that:

Maternal Outcomes Favor Induction

• Cesarean delivery rate: 18.6% with induction vs 22.2% with expectant management (RR 0.84, p<0.001) 1, 2
• Hypertensive disorders: 9.1% with induction vs 14.1% with expectant management (RR 0.64, p<0.001) 1
• Number needed to treat: Only 28 women need induction to prevent 1 cesarean delivery 1

Neonatal Outcomes Are Equivalent or Better

• Primary composite neonatal outcome (death or severe morbidity): 4.3% with induction vs 5.4% with expectant management (RR 0.80) 1, 2
• While this didn't reach statistical significance by the preset threshold, the trend favored induction
• No increase in adverse neonatal outcomes 2

Why the Closed Cervix Doesn't Change the Recommendation

Critically, 63% of women in the ARRIVE trial had an unfavorable cervix (Bishop score <5) at randomization 1. The benefits of induction persisted regardless of cervical favorability. This directly addresses your concern about the closed cervix—the evidence specifically supports induction even with an unfavorable cervix.

Supporting research confirms this: mathematical modeling showed that even among women with unfavorable cervices, 39-week induction resulted in fewer cesarean deliveries (8.0% vs 26.1%, p<0.01) compared to expectant management 3.

What Happens During Expectant Management

The guideline emphasizes a crucial point: during expectant management, complications can arise that make uncomplicated vaginal birth less likely 1. Specifically:

• Risk of developing hypertensive disorders increases significantly (14.1% vs 9.1%) 1
• Stillbirth risk, while low, is higher (0.13% vs 0% in modeling studies) 3
• Mean gestational age at delivery with expectant management is 40.0 weeks, meaning only a few days difference 1

Implementation Considerations

If you proceed with induction (recommended approach):

• Use cervical ripening agents for the unfavorable cervix 1
• Allow at least 12 hours after cervical ripening completion before considering cesarean for "failed induction" 1
• This patience is critical—premature cesarean decisions negate the benefits

If patient strongly prefers expectant management:

• Both options are reasonable per SMFM guidelines 1
• Close surveillance for hypertensive disorders is essential
• Plan delivery by 42 weeks 2 days 1
• Counsel about increased cesarean risk (22.2% vs 18.6%) 1

Common Pitfalls to Avoid

1. Don't abandon induction prematurely: The ARRIVE protocol specifically requested providers allow adequate time for cervical ripening and latent labor before declaring "failed induction" 1. Rushing to cesarean defeats the purpose.

2. Don't extrapolate to multiparous women: The evidence is specific to nulliparous women 1. Multiparous women have different risk profiles.

3. Don't ignore patient capacity and resources: Recent ACOG guidance acknowledges that implementation requires adequate hospital capacity and resources 4. However, this is a systems issue, not a reason to avoid offering induction when feasible.

The Bottom Line

The evidence strongly supports offering induction now rather than waiting 1, 2. The closed cervix is not a contraindication—most women in the pivotal trial had unfavorable cervices and still benefited. You'll reduce her cesarean risk by approximately 16% and cut her hypertensive disorder risk by 36%, with no increase in neonatal complications.